Skip to main content

Citius Pharmaceuticals, Inc.

CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506251

No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Citius Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CTXR: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders7372−1
Shares27.0M30.6M+3.62M (+13.4%)
Value$24.2M$17.9M−$6.35M (−26.2%)

New holders (19)

Institutions that held Citius Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CTXR in Q2 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC10,156,000$5.93M0.16%
Millennium Management LLC2,048,860$1.20M0.00%
Y-Intercept (Hong Kong) Ltd389,469$227.3K0.01%
Centiva Capital, LP275,000$160.5K0.01%
Qube Research & Technologies Ltd230,970$134.8K0.00%
Point72 Asia (Singapore) Pte. Ltd.201,876$117.8K0.02%
Citadel Advisors LLC185,614$108.3K0.00%
Cubist Systematic Strategies, LLC117,754$68.7K0.00%
HRT Financial LP100,099$58.0K0.00%
Schonfeld Strategic Advisors LLC77,600$45.3K0.00%
Mirae Asset Global ETFs Holdings Ltd.68,334$39.9K0.00%
Point72 (DIFC) Ltd49,820$29.1K0.00%
Paloma Partners Management Co47,554$27.8K0.00%
Jump Financial, LLC28,431$16.6K0.00%
Catalyst Funds Management Pty Ltd27,200$15.9K0.00%
Balyasny Asset Management LLC27,053$15.8K0.00%
Fairscale Capital, LLC9,155$7.78K0.01%
Macquarie Group Ltd6,887$4.02K0.00%
Russell Investments Group, Ltd.5,464$3.19K0.00%

Sold out (20)

Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.